Practical Guidance on Optimizing CLL Care in the Era of Molecular Therapies

This comprehensive program gathers CLL management insights from our distinguished CLL experts and features education on emerging and established treatment strategies enhanced by a decision support tool for individualizing these treatments to your patients. All aspects of this program are designed to complement each other, including the interactive treatment decision tool, expert commentaries, and an expert-authored CME/CE-certified module with downloadable slideset.
Emily Bucholtz Headshot
Emily Bucholtz, RPh
Nichole Fisher Headshot
Nichole Fisher, RN, BSN
Ian W. Flinn, MD, PhD
Susan M. O'Brien, MD
Jeff P. Sharman, MD


How do you treat patients with newly diagnosed CLL in the era of new agents? In this commentary, Dr. Flinn discusses emerging frontline combination regimens for the treatment of CLL.

Ian W. Flinn, MD, PhD Released: May 3, 2019

Are you aware of some of the latest clinical data in CLL? In this commentary, I will discuss 3 key studies on venetoclax, acalabrutinib, and lisocabtagene maraleucel in CLL that were presented at ASCO 2019.

Susan M. O'Brien, MD Released: June 27, 2019


Jeff P. Sharman, MD; Nichole Fisher, RN, BSN; and Emily Bucholtz, RPh, review patient cases and supporting clinical data to provide guidance on optimizing care for chronic lymphocytic leukemia.

Emily Bucholtz Headshot Emily Bucholtz, RPh Nichole Fisher Headshot Nichole Fisher, RN, BSN Jeff P. Sharman, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: July 17, 2019 Expiration: July 16, 2020

Downloadable Slideset

Download these slides to review the most recent clinical data on new agents in both frontline and relapsed/refractory CLL.

Emily Bucholtz Headshot Emily Bucholtz, RPh Nichole Fisher Headshot Nichole Fisher, RN, BSN Jeff P. Sharman, MD Released: July 17, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Produced in collaboration with
CLL Society Logo
Supported by educational grants from
Pharmacyclics LLC, An AbbVie Company
Verastem Oncology

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?